This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Health Care Stocks With 100% Buy Ratings

2. Clinical Data (CLDA) develops therapeutics as well as genetic and pharmacogenomic investigation techniques for diagnosing serious diseases, and for predicting drug safety, tolerability and efficacy.

Analysts polled by Bloomberg expect the company to report a loss of 47 cents per share for the third quarter of fiscal year 2011 ended Dec. 31, 2010, in comparison to a loss of 63 cents per share and a loss of 56 cents per share in the year-ago and quarter-ago periods, respectively. Clinical Data is anticipated to turn profitable in the September quarter of 2012.

The stock surged around 58% during the past one year, while Life Technologies (LIFE), Covance (CVD), Pharmaceutical Product Development (PPDI), Charles River Laboratories (CRL) and SeaCare Life Sciences (SRLS) posted returns of around 11%, -4%, 34%, 0.5%, and 33%, respectively.

All the seven analysts covering the stock recommend buying. Analysts expect the stock to gain around 36% over the next 12 months with a consensus target price of $34.4.
10 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CO $6.21 -0.16%
DCTH $0.32 -4.40%
HSTM $22.96 -0.65%
STXS $1.45 -6.50%
VASC $35.11 -0.06%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs